ICON’s ICLR focus on Patient Access & Engagement strategy is a major tailwind along with partnerships and acquisitions. The stock carries a Zacks Rank #2 (Buy) currently. ICON is gaining from its ...

ICON plc’s ICLR focus on Patient Access & Engagement strategy and favorable CRO industry trends are major tailwinds. Strategic partnerships are an added plus. The stock carries a Zacks Rank #2 (Buy) ...

Earnings Call Insights: ICON Public Limited Company (NASDAQ:ICLR) Q4 2024 CEO Steve Cutler introduced Barry Balfe as the ...

The company anticipates continued volatility in bookings due to customer caution and reprioritizations. Elevated cancellation rates are expected to persist throughout 2025. Guidance for 2025 reflects ...

Earnings Call Insights: ICON Public Limited Company (ICLR) Q1 2025 The company anticipates continued volatility in bookings due to customer caution and reprioritizations. Elevated cancellation rates ...